Linked Life Data

19785834

Source:http://linkedlifedata.com/resource/pubmed/id/19785834

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2009-9-29
pubmed:abstractText
The publication of a practice guideline for primary and secondary prevention of cervical cancer by the Dutch College of General Practitioners was appropriate since the vaccination against two high-risk human papillomaviruses (hr-HPV 16 and 18) was recently included in the National Immunization Programme of the Netherlands. Despite vaccination, population-based screening for cervical neoplasia needs to be continued. Moreover, it will take over a decade before vaccination will affect the prevalence of cervical neoplasia. Short term improvement of prevention of cervical neoplasia should therefore focus on screening technology and strategy. Molecular tests based on detection of hr-HPV or DNA changes occurring early in cervical carcinogenesis might improve the efficacy of the screening, which in the Netherlands is currently done by Pap smear. In addition, the high number of women not responding on an invitation for screening might be reduced by a self-sampling approach.
pubmed:commentsCorrections
pubmed:language
dut
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1876-8784
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
153
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
A628
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
[New strategies for screening cervical cancer; response to the Dutch College of General Practitioner's practice guideline 'Prevention and early diagnosis of cervical cancer'].
pubmed:affiliation
Universitair Medisch Centrum Groningen, afd. Obstetrie en Gynaecologie, subafd. Gynaecologische Oncologie, Groningen, The Netherlands.
pubmed:publicationType
Journal Article, Comment, English Abstract